Bill Text: IL HB3873 | 2023-2024 | 103rd General Assembly | Introduced

---

Bill Title: Amends the Illinois Controlled Substances Act. Schedules xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, as a Schedule II controlled substance.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Failed) 2025-01-07 - Session Sine Die [HB3873 Detail]

Download: Illinois-2023-HB3873-Introduced.html

---

103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3873 Introduced , by Rep. Jackie Haas SYNOPSIS AS INTRODUCED:
720 ILCS 570/206 from Ch. 56 1/2, par. 1206
Amends the Illinois Controlled Substances Act. Schedules Xylazine: (N-2,6-dimethylpheny1)-5,6-dihydro-4H-1,3 thiazin-2-amine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation as a Schedule II controlled substance.
LRB103 31050 RLC 57668 b
A BILL FOR
HB3873 LRB103 31050 RLC 57668 b
AN ACT concerning criminal law.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Illinois Controlled Substances Act is
amended by changing Section 206 as follows:
(720 ILCS 570/206) (from Ch. 56 1/2, par. 1206)
Sec. 206. (a) The controlled substances listed in this
Section are included in Schedule II.
(b) Unless specifically excepted or unless listed in
another schedule, any of the following substances whether
produced directly or indirectly by extraction from substances
of vegetable origin, or independently by means of chemical
synthesis, or by combination of extraction and chemical
synthesis:
(1) Opium and opiates, and any salt, compound,
derivative or preparation of opium or opiate, excluding
apomorphine, dextrorphan, levopropoxyphene, nalbuphine,
nalmefene, naloxone, and naltrexone, and their respective
salts, but including the following:
(i) Raw Opium;
(ii) Opium extracts;
(iii) Opium fluid extracts;
(iv) Powdered opium;

HB3873 - 2 - LRB103 31050 RLC 57668 b
(v) Granulated opium;
(vi) Tincture of opium;
(vii) Codeine;
(viii) Ethylmorphine;
(ix) Etorphine Hydrochloride;
(x) Hydrocodone;
(xi) Hydromorphone;
(xii) Metopon;
(xiii) Morphine;
(xiii.5) 6-Monoacetylmorphine;
(xiv) Oxycodone;
(xv) Oxymorphone;
(xv.5) Tapentadol;
(xvi) Thebaine;
(xvii) Thebaine-derived butorphanol.
(xviii) Methorphan, except drug products
containing dextromethorphan that may be dispensed
pursuant to a prescription order of a practitioner and
are sold in compliance with the safety and labeling
standards as set forth by the United States Food and
Drug Administration, or drug products containing
dextromethorphan that are sold in solid, tablet,
liquid, capsule, powder, thin film, or gel form and
which are formulated, packaged, and sold in dosages
and concentrations for use as an over-the-counter drug
product. For the purposes of this Section,

HB3873 - 3 - LRB103 31050 RLC 57668 b
"over-the-counter drug product" means a drug that is
available to consumers without a prescription and sold
in compliance with the safety and labeling standards
as set forth by the United States Food and Drug
Administration.
(2) Any salt, compound, isomer, derivative or
preparation thereof which is chemically equivalent or
identical with any of the substances referred to in
subparagraph (1), but not including the isoquinoline
alkaloids of opium;
(3) Opium poppy and poppy straw;
(4) Coca leaves and any salt, compound, isomer, salt
of an isomer, derivative, or preparation of coca leaves
including cocaine or ecgonine, and any salt, compound,
isomer, derivative, or preparation thereof which is
chemically equivalent or identical with any of these
substances, but not including decocainized coca leaves or
extractions of coca leaves which do not contain cocaine or
ecgonine (for the purpose of this paragraph, the term
"isomer" includes optical, positional and geometric
isomers);
(5) Concentrate of poppy straw (the crude extract of
poppy straw in either liquid, solid or powder form which
contains the phenanthrine alkaloids of the opium poppy).
(c) Unless specifically excepted or unless listed in
another schedule any of the following opiates, including their

HB3873 - 4 - LRB103 31050 RLC 57668 b
isomers, esters, ethers, salts, and salts of isomers, whenever
the existence of these isomers, esters, ethers and salts is
possible within the specific chemical designation, dextrorphan
excepted:
(1) Alfentanil;
(1.1) Carfentanil;
(1.2) Thiafentanyl;
(2) Alphaprodine;
(3) Anileridine;
(4) Bezitramide;
(5) Bulk Dextropropoxyphene (non-dosage forms);
(6) Dihydrocodeine;
(7) Diphenoxylate;
(8) Fentanyl;
(8.5) Xylazine: (N-2,6-dimethylpheny1)-5,6-
dihydro-4H-1,3 thiazin-2-amine), including its isomers,
esters, ethers, salts, and salts of isomers, esters, and
ethers, whenever the existence of such isomers, esters,
ethers, and salts is possible within the specific chemical
designation;
(9) Sufentanil;
(9.5) Remifentanil;
(10) Isomethadone;
(11) (Blank);
(12) Levorphanol (Levorphan);
(13) Metazocine;

HB3873 - 5 - LRB103 31050 RLC 57668 b
(14) Methadone;
(15) Methadone-Intermediate,
4-cyano-2-dimethylamino-4,4-diphenyl-1-butane;
(16) Moramide-Intermediate,
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic
acid;
(17) Pethidine (meperidine);
(18) Pethidine-Intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine;
(19) Pethidine-Intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate;
(20) Pethidine-Intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid;
(21) Phenazocine;
(22) Piminodine;
(23) Racemethorphan;
(24) (Blank);
(25) Levo-alphacetylmethadol (some other names:
levo-alpha-acetylmethadol, levomethadyl acetate, LAAM).
(d) Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous
system:
(1) Amphetamine, its salts, optical isomers, and salts
of its optical isomers;

HB3873 - 6 - LRB103 31050 RLC 57668 b
(2) Methamphetamine, its salts, isomers, and salts of
its isomers;
(3) Phenmetrazine and its salts;
(4) Methylphenidate;
(5) Lisdexamfetamine.
(e) Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
substances having a depressant effect on the central nervous
system, including its salts, isomers, and salts of isomers
whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation:
(1) Amobarbital;
(2) Secobarbital;
(3) Pentobarbital;
(4) Pentazocine;
(5) Phencyclidine;
(6) Gluthethimide;
(7) (Blank).
(f) Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following
substances:
(1) Immediate precursor to amphetamine and
methamphetamine:
(i) Phenylacetone

HB3873 - 7 - LRB103 31050 RLC 57668 b
Some trade or other names: phenyl-2-propanone;
P2P; benzyl methyl ketone; methyl benzyl ketone.
(2) Immediate precursors to phencyclidine:
(i) 1-phenylcyclohexylamine;
(ii) 1-piperidinocyclohexanecarbonitrile (PCC).
(3) Nabilone.
(Source: P.A. 100-368, eff. 1-1-18.)